cediranib

cediranib
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 2010-12-13 00:00:00
Sponsor National Institutes of Health;National Cancer Institute, 9609 Medical Center Dr.;Bethesda, Maryland, 20892